Breast cancer liver metastases represent a formidable clinical challenge and are frequently associated with poorer prognoses. Historically viewed as a manifestation of systemic disease, current ...

A comprehensive analysis of breast cancer metastases compares various methods and affords new insights into the biology of tumors. A comprehensive analysis of breast cancer metastases compares various ...

The biotech firm focused on fighting breast cancer was recently selected to the prestigious Charles River Cell & Gene Therapy ...

(Patients with disseminated metastatic disease from breast cancer are likely to have liver involvement in >50% of cases at some point during disease progression.) Zetagen identifies two concentrations ...

The drug dexamethasone supplements cancer treatments to alleviate side effects of chemotherapy such as nausea or inflammation. Researchers at the University of Basel, Switzerland, have now discovered ...

Pfizer Inc.’s Tukysa, when given as part of the initial treatment for an advanced form of breast cancer, delayed tumor growth by more than eight months, according to a study that may expand its use.

SABCS 2025 analysis shows persistent racial and socioeconomic gaps in metastatic HR+/HER2 negative breast cancer diagnosis ...

Tumor cells circulating in the blood are the "germ cells" of breast cancer metastases. They are very rare and could not be propagated in the culture dish until now, which made research into therapy ...

So in summary, HER2CLIMB-05 was a positive study. It showed that adding tucatinib for both HR-positive as well as HR-negative ...

New NATALEE 5-year sub-analysis data reinforce sustained reduction in distant disease-free survival in broadest population of EBC patients13 ...